Biomedicines | Hot Papers in the “Endocrinology and Metabolism Research” Section

The Section “Endocrinology and Metabolism Research” of Biomedicines (ISSN: 2227-9059) publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of endocrinology and metabolism. Papers aiming to uncover molecular and cellular mechanisms in endocrinology and metabolism are welcome. Topics include, but are not limited to, gene regulation, cell biology, signaling, mutations, growth factors, cytokines, hormone receptors, hormone action and regulation, developmental endocrinology, genetic endocrinology, endocrine diseases (diabetes, obesity, osteoporosis, hyperthyroidism, etc.), and metabolic diseases.

Please feel free to read the following papers:

1. “Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome”
by Ana Teresa Brinca, Ana Cristina Ramalhinho, Ângela Sousa, António Hélio Oliani, Luiza Breitenfeld, Luís A. Passarinha and Eugenia Gallardo
Biomedicines 2022, 10(6), 1254; https://doi.org/10.3390/biomedicines10061254
Available online: https://www.mdpi.com/2227-9059/10/6/1254

2. “2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus”
by Luca Navarini, Marta Vomero, Stefano Di Donato, Damiano Currado, Onorina Berardicurti, Annalisa Marino, Pietro Bearzi, Alice Biaggi, Matteo Ferrito, Piero Ruscitti et al.
Biomedicines 2022, 10(7), 1675; https://doi.org/10.3390/biomedicines10071675
Available online: https://www.mdpi.com/2227-9059/10/7/1675

3. “The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside—A Systematic Literature Review”
by Salvatore Giovanni Vitale, Anna Maria Fulghesu, Mislav Mikuš, Rafał Watrowski, Maurizio Nicola D’Alterio, Li-Te Lin, Mohsin Shah, Enrique Reyes-Muñoz, Thozhukat Sathyapalan and Stefano Angioni
Biomedicines 2022, 10(8), 1816; https://doi.org/10.3390/biomedicines10081816
Available online: https://www.mdpi.com/2227-9059/10/8/1816

4. “Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome”
by Dorte Glintborg, Naja Due Kolster, Pernille Ravn and Marianne Skovsager Andersen
Biomedicines 2022, 10(6), 1455; https://doi.org/10.3390/biomedicines10061455
Available online: https://www.mdpi.com/2227-9059/10/6/1455

5. “Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia”
by Giuseppe Mandraffino, Carmela Morace, Maria Stella Franzè, Veronica Nassisi, Davide Sinicropi, Maria Cinquegrani, Carlo Saitta, Riccardo Scoglio, Sebastiano Marino, Alessandra Belvedere et al.
Biomedicines 2022, 10(8), 1770; https://doi.org/10.3390/biomedicines10081770
Available online: https://www.mdpi.com/2227-9059/10/8/1770

6. “Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives”
by Mojca Jensterle, Rok Herman and Andrej Janež
Biomedicines 2022, 10(8), 1989; https://doi.org/10.3390/biomedicines10081989
Available online: https://www.mdpi.com/2227-9059/10/8/1989

7. “Impact of Thyroid Function on Pregnancy and Neonatal Outcome in Women with and without PCOS”
by Sarah Feigl, Barbara Obermayer-Pietsch, Philipp Klaritsch, Gudrun Pregartner, Sereina Annik Herzog, Elisabeth Lerchbaum, Christian Trummer, Stefan Pilz and Martina Kollmann
Biomedicines 2022, 10(4), 750; https://doi.org/10.3390/biomedicines10040750
Available online: https://www.mdpi.com/2227-9059/10/4/750

8. “Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease”
by Louise S. Dalbøge, Michael Christensen, Martin Rønn Madsen, Thomas Secher, Nicole Endlich, Vedran Drenic’, Alba Manresa-Arraut, Henrik H. Hansen, Ida Rune, Lisbeth N. Fink et al.
Biomedicines 2022, 10(7), 1661; https://doi.org/10.3390/biomedicines10071661
Available online: https://www.mdpi.com/2227-9059/10/7/1661

9. “Cortisol as an Independent Predictor of Unfavorable Outcomes in Hospitalized COVID-19 Patients”
by Renata Świątkowska-Stodulska, Agata Berlińska and Ewelina Puchalska-Reglińska
Biomedicines 2022, 10(7), 1527; https://doi.org/10.3390/biomedicines10071527
Available online: https://www.mdpi.com/2227-9059/10/7/1527

10. “Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial”
by Katharina Lechner, Clemens von Schacky, Johannes Scherr, Elke Lorenz, Matthias Bock, Benjamin Lechner, Bernhard Haller, Alexander Krannich, Martin Halle, Rolf Wachter et al.
Biomedicines 2022, 10(9), 2296; https://doi.org/10.3390/biomedicines10092296
Available online: https://www.mdpi.com/2227-9059/10/9/2296

We would appreciate it if you would circulate the link of any papers you find appealing throughout your network. Furthermore, the following opportunities for collaboration may be of interest:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field. Proposals may be submitted via the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Joining the Editorial Board:
We are looking for active scholars who are interested in and passionate about helping with the selection of submissions. Please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office